Avidity biosciences announces upcoming presentations at the 30th annual fshd society international research congress

San diego , june 8, 2023 /prnewswire/ -- avidity biosciences, inc. (nasdaq: rna), a biopharmaceutical company committed to delivering a new class of rna therapeutics called antibody oligonucleotide conjugates (aocs™), today announced that the company will be presenting two oral presentations and two poster presentations at the 30th annual fshd society international research congress, being held june 15-16, 2023, in milan, italy. oral presentations june 15, 2023: 5:10 p.m.
RNA Ratings Summary
RNA Quant Ranking